Robyn D. Richardson

507 total citations
9 papers, 426 citations indexed

About

Robyn D. Richardson is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Robyn D. Richardson has authored 9 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Robyn D. Richardson's work include Peroxisome Proliferator-Activated Receptors (5 papers), Cancer, Lipids, and Metabolism (5 papers) and Lipid metabolism and biosynthesis (2 papers). Robyn D. Richardson is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (5 papers), Cancer, Lipids, and Metabolism (5 papers) and Lipid metabolism and biosynthesis (2 papers). Robyn D. Richardson collaborates with scholars based in United States and Germany. Robyn D. Richardson's co-authors include Jeffrey W. Smith, Daniel Romo, Amy L. Howes, Kristiina Vuori, Darren Finlay, Colin G. Ferguson, Glenn D. Prestwich, Vikram C. Purohit, Wouter H. Moolenaar and Laurens A. van Meeteren and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Robyn D. Richardson

9 papers receiving 420 citations

Peers

Countries citing papers authored by Robyn D. Richardson

Since Specialization

Citations

This map shows the geographic impact of Robyn D. Richardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn D. Richardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn D. Richardson more than expected).

Fields of papers citing papers by Robyn D. Richardson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn D. Richardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn D. Richardson. The network helps show where Robyn D. Richardson may publish in the future.

Co-authorship network of co-authors of Robyn D. Richardson

This figure shows the co-authorship network connecting the top 25 collaborators of Robyn D. Richardson. A scholar is included among the top collaborators of Robyn D. Richardson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robyn D. Richardson. Robyn D. Richardson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids 2017 ·Bioorganic & Medicinal Chemistry ·Mingzhao Zhu, Wayne Harshbarger, Omar Robles, Joanna Krysiak, Kenneth G. Hull, (unknown), Robyn D. Richardson, Yanyan Yang, Andrés González García, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), James C. Sacchettini, Wenshe Ray Liu, Stephan A. Sieber, Jeffrey W. Smith, Daniel Romo	12
2	3-Dimensional Culture Systems for Anti-Cancer Compound Profiling and High-Throughput Screening Reveal Increases in EGFR Inhibitor-Mediated Cytotoxicity Compared to Monolayer Culture Systems 2014 ·PLoS ONE ·Amy L. Howes, Robyn D. Richardson, Darren Finlay, Kristiina Vuori	100
3	Novel HTS Strategy Identifies TRAIL-Sensitizing Compounds Acting Specifically Through the Caspase-8 Apoptotic Axis 2010 ·PLoS ONE ·Darren Finlay, Robyn D. Richardson, (unknown), Amy L. Howes, Kristiina Vuori	16
4	β-Lactam congeners of orlistat as inhibitors of fatty acid synthase 2008 ·Bioorganic & Medicinal Chemistry Letters ·Wei Zhang, Robyn D. Richardson, Supakarn Chamni, Jeffrey W. Smith, Daniel Romo	17
5	Synthesis of Novel β-Lactone Inhibitors of Fatty Acid Synthase 2008 ·Journal of Medicinal Chemistry ·Robyn D. Richardson, Gil Ma, (unknown), Manuel Zancanella, Lynn M. Knowles, Piotr Cieplak, Daniel Romo, Jeffrey W. Smith	42
6	Novel antagonists of the thioesterase domain of human fatty acid synthase 2007 ·Molecular Cancer Therapeutics ·Robyn D. Richardson, Jeffrey W. Smith	22
7	Practical, Catalytic, Asymmetric Synthesis of β-Lactones via a Sequential Ketene Dimerization/Hydrogenation Process: Inhibitors of the Thioesterase Domain of Fatty Acid Synthase 2006 ·The Journal of Organic Chemistry ·Vikram C. Purohit, Robyn D. Richardson, Jeffrey W. Smith, Daniel Romo	62
8	Fluorogenic Phospholipid Substrate to Detect Lysophospholipase D/Autotaxin Activity 2006 ·Organic Letters ·Colin G. Ferguson, (unknown), Robyn D. Richardson, Laurens A. van Meeteren, Wouter H. Moolenaar, Glenn D. Prestwich	94
9	Total Synthesis and Comparative Analysis of Orlistat, Valilactone, and a Transposed Orlistat Derivative: Inhibitors of Fatty Acid Synthase 2006 ·Organic Letters ·Gil Ma, Manuel Zancanella, (unknown), Robyn D. Richardson, Jeffrey W. Smith, Daniel Romo	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact